Dirk Garmann
Dirk Garmann publishes mostly in Cardiology and Cardiovascular Medicine, Hematology and Molecular Biology, on topics such as Atrial Fibrillation Management and Outcomes, Hemophilia Treatment and Research and Venous Thromboembolism Diagnosis and Management.
- World rank
- #3,373,504 of 7,710,434 ranked researchers
- Rank in Germany
- #168,361 of 364,343
- Works
- 40
- Citations
- 712
- Citations per work
- 17.8
What does Dirk Garmann research?
Dirk Garmann's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2152.2%
- Medicine2152.2%
- Everything else1640.7%
- Life Sciences37.1%
- 1Cardiology and Cardiovascular Medicine20% of their works
- 2Hematology15% of their works
- 3Molecular Biology7% of their works
- 4Endocrinology, Diabetes and Metabolism6% of their works
- 5Oncology6% of their works
- 6Genetics5% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Hemophilia Treatment and Research
- Venous Thromboembolism Diagnosis and Management
- Lymphoma Diagnosis and Treatment
- Hormonal Regulation and Hypertension
- Blood Coagulation and Thrombosis Mechanisms
- Metal complexes synthesis and properties
- Cardiac electrophysiology and arrhythmias
Which keywords describe Dirk Garmann's research?
The keywords of their largest research topics: Prophylaxis, Antithrombotic Therapy, Anticoagulant Therapy, Atrial Fibrillation, Factor VIII, Hemophilia, Pulmonary Embolism and Venous Thromboembolism.
- Long-QT Syndrome
- Thrombin
- Primary Aldosteronism
- Cisplatin Resistance
- Lymphoma
- Venous Thromboembolism
- Hemophilia
- Atrial Fibrillation
- Antithrombotic Therapy
- Prophylaxis
- Anticoagulant Therapy
- Factor VIII
- Pulmonary Embolism
- Classification
- Aldosterone
- Platinum-Based Drugs
- Protease-Activated Receptors
- Arrhythmias
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prophylaxis122 topics
- Antithrombotic Therapy102 topics
- Anticoagulant Therapy91 topic
- Atrial Fibrillation91 topic
- Factor VIII61 topic
- Hemophilia61 topic
- Pulmonary Embolism61 topic
- Venous Thromboembolism61 topic
- Classification51 topic
- Lymphoma51 topic
- Aldosterone41 topic
- Cisplatin Resistance41 topic
- Platinum-Based Drugs41 topic
- Primary Aldosteronism41 topic
- Protease-Activated Receptors41 topic
- Thrombin41 topic
- Arrhythmias31 topic
- Long-QT Syndrome31 topic
Where does Dirk Garmann work?
Dirk Garmann's main affiliation in the publication record is Bayer (Germany), Germany.
How many publications and citations does Dirk Garmann have?
OpenAlex counts 40 works and 712 citations for Dirk Garmann, an h-index of 15, ranking #3,373,504 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dirk Garmann. Posts are plain text and can be reported.